At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Mar 4, 2026 at 19:00 ET
A director at Dyne Therapeutics sold $2.53 million worth of shares in a single open-market transaction, representing a notable insider divestment. This sale accounts for approximately 0.08% of the company's $3.0B market cap and is consistent with recent insider selling activity totaling $2.6M over the past 30 days.
- Director Kersten Dirk sold 129,672 shares at $19.5151 per share for a total of $2,530,562.
- The transaction was an open-market sale (Form 4 code 'S').
- This sale represents approximately 0.08% of Dyne Therapeutics' $3.0B market capitalization.
- It is part of a broader pattern of insider selling, with four sales totaling $2.6M in the past 30 days.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access